Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Another market launch for Orion's COMT inhibitor

Dec. 17, 1998

Zeneca's new pain-relieving agents revealed in patent literature

Dec. 17, 1998

Studies using 5-ht6 antagonist Ro-04-6790 provide new clues about receptor function

Dec. 17, 1998

NPS Pharmaceuticals updates epilepsy program

Dec. 17, 1998

Novel glutamate receptor antagonist shows excellent potential as antiepileptic agent

Dec. 15, 1998

Merckle launches new treatment for narcolepsy in Germany

Dec. 15, 1998

New U.S. patent provides Cortex exclusivity for Ampakine compounds

Dec. 14, 1998

Another series of adenosine kinase inhibitors patented by Abbott

Dec. 11, 1998

Quinolinomorphinans for ischemic, hemorrhagic, traumatic or degenerative brain disorders

Dec. 11, 1998

Wide series of adenosine kinase inhibitors undergoing evaluation at Abbott

Dec. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...